menu
    • menu

    Company profile for Transcenta Holding

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a group of people with passion and experience for developing innovative medicines to serve patients around the world. We operate globally and focus on biologics, and we have established a fully integrated capability with a Discovery, Clinical and Translational Research Center in Suzhou, a Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Shanghai, Beijing ...
    We are a group of people with passion and experience for developing innovative medicines to serve patients around the world. We operate globally and focus on biologics, and we have established a fully integrated capability with a Discovery, Clinical and Translational Research Center in Suzhou, a Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Shanghai, Beijing and Princeton, US, and an External Partnering Center in Boston, US.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Transcenta HoldingChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Biobay B6-501, Suzhou
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.transcenta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/transcenta
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Transcenta Highlights LIV-1 ADC Efficacy In TNBC Tumor At SABCS
    Transcenta Highlights LIV-1 ADC Efficacy In TNBC Tumor At SABCS

    12 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-debuts-promising-anti-tumor-activity-of-novel-liv-1-targeting-adcs-with-site-specific-conjugated-topo-i-inhibitor-payload-in-tnbc-tumor-models-at-2024-sabcs-302330235.html

    PR NEWSWIRE
    12 Dec 2024
    Share Share
    Transcenta Shows Efficacy of Osemitamab in G/GEJ Cancer at ESMO 2024
    Transcenta Shows Efficacy of Osemitamab in G/GEJ Cancer at ESMO 2024

    18 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-updates-encouraging-efficacy-data-from-first-line-triple-combo-trial-of-osemitamab-tst001-for-ggej-cancer-at-esmo-2024-302251645.html

    PR NEWSWIRE
    18 Sep 2024
    Share Share
    Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
    Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

    29 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html

    PR NEWSWIRE
    29 Aug 2024
    Share Share
    Transcenta collaborates Agilent to develop Claudin18.2 to support Osemitamab
    Transcenta collaborates Agilent to develop Claudin18.2 to support Osemitamab

    09 Apr 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168441&sid=2

    PHARMABIZ
    09 Apr 2024
    Share Share
    Transcenta Collab with Agilent to Develop a Claudin18.2 Companion Diagnostic
    Transcenta Collab with Agilent to Develop a Claudin18.2 Companion Diagnostic

    08 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-announces-collaboration-with-agilent-to-develop-a-claudin18-2-companion-diagnostic-to-support-osemitamab-tst001-global-phase-iii-trial-302111036.html

    PR NEWSWIRE
    08 Apr 2024
    Share Share
    Transcenta Announces the Publication of Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate
    Transcenta Announces the Publication of Results of [177Lu]Lu-TST001 Radionuclide Antibody Conjugate

    13 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-announces-the-publication-of-preclinical-results-of-177lulu-tst001-radionuclide-antibody-conjugate-as-potential-novel-treatment-option-for-metastatic-gastric-cancer-in-the-european-journal-of-nuclear-medicine-and-mole-302013860.html

    PR NEWSWIRE
    13 Dec 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search